Trial Outcomes & Findings for Financial Incentives to Increase Pediatric HIV Testing (NCT NCT03049917)
NCT ID: NCT03049917
Last Updated: 2021-06-25
Results Overview
Number of caregivers who present child(ren) to complete HIV testing at the study clinic within 2 months of recruitment; test results will be recorded in a study questionnaire
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
452 participants
Primary outcome timeframe
2 months
Results posted on
2021-06-25
Participant Flow
Participant milestones
| Measure |
No Incentive
KES financial incentive = $0
|
KES Financial Incentive 1
KES financial incentive 1= $1.25
|
KES Financial Incentive 2
KES financial incentive 2= $2.50
|
KES Financial Incentive 3
KES financial incentive 3= $5
|
KES Financial Incentive 4
KES financial incentive 4= $10
|
|---|---|---|---|---|---|
|
Overall Study
STARTED
|
90
|
89
|
93
|
92
|
88
|
|
Overall Study
COMPLETED
|
31
|
31
|
44
|
51
|
54
|
|
Overall Study
NOT COMPLETED
|
59
|
58
|
49
|
41
|
34
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Financial Incentives to Increase Pediatric HIV Testing
Baseline characteristics by cohort
| Measure |
No Incentive
n=90 Participants
KES financial incentive= $0
|
KES Financial Incentive 1
n=89 Participants
KES financial incentive 1= $1.25
|
KES Financial Incentive 2
n=93 Participants
KES financial incentive 2= $2.50
|
KES Financial Incentive 3
n=92 Participants
KES financial incentive 3= $5
|
KES Financial Incentive 4
n=88 Participants
KES financial incentive 4= $10
|
Total
n=452 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
90 Participants
n=5 Participants
|
89 Participants
n=7 Participants
|
93 Participants
n=5 Participants
|
92 Participants
n=4 Participants
|
88 Participants
n=21 Participants
|
452 Participants
n=8 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Age, Continuous
|
37.5 years
n=5 Participants
|
37 years
n=7 Participants
|
38 years
n=5 Participants
|
38 years
n=4 Participants
|
39.5 years
n=21 Participants
|
38 years
n=8 Participants
|
|
Sex: Female, Male
Female
|
64 Participants
n=5 Participants
|
62 Participants
n=7 Participants
|
65 Participants
n=5 Participants
|
55 Participants
n=4 Participants
|
59 Participants
n=21 Participants
|
305 Participants
n=8 Participants
|
|
Sex: Female, Male
Male
|
26 Participants
n=5 Participants
|
27 Participants
n=7 Participants
|
28 Participants
n=5 Participants
|
37 Participants
n=4 Participants
|
29 Participants
n=21 Participants
|
147 Participants
n=8 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Black or African American
|
90 Participants
n=5 Participants
|
89 Participants
n=7 Participants
|
93 Participants
n=5 Participants
|
92 Participants
n=4 Participants
|
88 Participants
n=21 Participants
|
452 Participants
n=8 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Overall number of baseline participants
|
90 Participants
n=5 Participants
|
89 Participants
n=7 Participants
|
93 Participants
n=5 Participants
|
92 Participants
n=4 Participants
|
88 Participants
n=21 Participants
|
452 Participants
n=8 Participants
|
PRIMARY outcome
Timeframe: 2 monthsNumber of caregivers who present child(ren) to complete HIV testing at the study clinic within 2 months of recruitment; test results will be recorded in a study questionnaire
Outcome measures
| Measure |
No Incentive
n=90 Participants
KES financial incentive=$0
|
KES Financial Incentive 1
n=89 Participants
KES financial incentive 1=$1.25
|
KES Financial Incentive 2
n=93 Participants
KES financial incentive 2=$2.50
|
KES Financial Incentive 3
n=92 Participants
KES financial incentive 3=$5
|
KES Financial Incentive 4
n=88 Participants
KES financial incentive 4=$10
|
All Females
Total females enrolled
|
|---|---|---|---|---|---|---|
|
Number of Participants Who Present Children for HIV Testing
|
31 Participants
|
31 Participants
|
44 Participants
|
51 Participants
|
54 Participants
|
—
|
PRIMARY outcome
Timeframe: 2 monthsNumber of days it took between randomization and caregiver presenting the child for HIV testing
Outcome measures
| Measure |
No Incentive
n=90 Participants
KES financial incentive=$0
|
KES Financial Incentive 1
n=89 Participants
KES financial incentive 1=$1.25
|
KES Financial Incentive 2
n=93 Participants
KES financial incentive 2=$2.50
|
KES Financial Incentive 3
n=92 Participants
KES financial incentive 3=$5
|
KES Financial Incentive 4
n=88 Participants
KES financial incentive 4=$10
|
All Females
Total females enrolled
|
|---|---|---|---|---|---|---|
|
Number of Days Participants Take to Bring Children for HIV Testing
|
8 days
Interval 3.0 to 23.0
|
7 days
Interval 4.0 to 14.0
|
4 days
Interval 1.0 to 11.0
|
5 days
Interval 2.0 to 14.0
|
5 days
Interval 2.0 to 8.0
|
—
|
SECONDARY outcome
Timeframe: 2 monthsHIV testing \[primary outcome 1\] stratified by caregiver sex (females)
Outcome measures
| Measure |
No Incentive
n=64 Participants
KES financial incentive=$0
|
KES Financial Incentive 1
n=62 Participants
KES financial incentive 1=$1.25
|
KES Financial Incentive 2
n=65 Participants
KES financial incentive 2=$2.50
|
KES Financial Incentive 3
n=55 Participants
KES financial incentive 3=$5
|
KES Financial Incentive 4
n=59 Participants
KES financial incentive 4=$10
|
All Females
n=305 Participants
Total females enrolled
|
|---|---|---|---|---|---|---|
|
Number of Female Participants Who Present Children for HIV Testing (Females)
|
25 Participants
|
22 Participants
|
34 Participants
|
29 Participants
|
38 Participants
|
156 Participants
|
SECONDARY outcome
Timeframe: 2 monthsTime to HIV testing \[primary outcome 1\] stratified by caregiver sex (males)
Outcome measures
| Measure |
No Incentive
n=26 Participants
KES financial incentive=$0
|
KES Financial Incentive 1
n=27 Participants
KES financial incentive 1=$1.25
|
KES Financial Incentive 2
n=28 Participants
KES financial incentive 2=$2.50
|
KES Financial Incentive 3
n=37 Participants
KES financial incentive 3=$5
|
KES Financial Incentive 4
n=29 Participants
KES financial incentive 4=$10
|
All Females
n=147 Participants
Total females enrolled
|
|---|---|---|---|---|---|---|
|
Number of Male Participants Who Present Children for HIV Testing
|
6 Participants
|
9 Participants
|
10 Participants
|
22 Participants
|
16 Participants
|
55 Participants
|
SECONDARY outcome
Timeframe: 2 monthsHIV testing \[primary outcome 1\] stratified by number of children (one child)
Outcome measures
| Measure |
No Incentive
n=42 Participants
KES financial incentive=$0
|
KES Financial Incentive 1
n=41 Participants
KES financial incentive 1=$1.25
|
KES Financial Incentive 2
n=33 Participants
KES financial incentive 2=$2.50
|
KES Financial Incentive 3
n=36 Participants
KES financial incentive 3=$5
|
KES Financial Incentive 4
n=38 Participants
KES financial incentive 4=$10
|
All Females
n=190 Participants
Total females enrolled
|
|---|---|---|---|---|---|---|
|
Number of Caregivers With One Child Who Present Children for HIV Testing
|
15 Participants
|
14 Participants
|
26 Participants
|
29 Participants
|
32 Participants
|
90 Participants
|
SECONDARY outcome
Timeframe: 2 monthsNumber of participants presenting children for HIV testing among caregivers with more than child
Outcome measures
| Measure |
No Incentive
n=47 Participants
KES financial incentive=$0
|
KES Financial Incentive 1
n=48 Participants
KES financial incentive 1=$1.25
|
KES Financial Incentive 2
n=58 Participants
KES financial incentive 2=$2.50
|
KES Financial Incentive 3
n=55 Participants
KES financial incentive 3=$5
|
KES Financial Incentive 4
n=49 Participants
KES financial incentive 4=$10
|
All Females
n=257 Participants
Total females enrolled
|
|---|---|---|---|---|---|---|
|
Number of Participants With More Than 1 Child Who Present Children for HIV Testing
|
15 Participants
|
17 Participants
|
16 Participants
|
21 Participants
|
21 Participants
|
116 Participants
|
SECONDARY outcome
Timeframe: 2 monthsNumber of participants presenting for HIV testing stratified by caregiver age (caregiver \<=38 years)
Outcome measures
| Measure |
No Incentive
n=47 Participants
KES financial incentive=$0
|
KES Financial Incentive 1
n=50 Participants
KES financial incentive 1=$1.25
|
KES Financial Incentive 2
n=50 Participants
KES financial incentive 2=$2.50
|
KES Financial Incentive 3
n=47 Participants
KES financial incentive 3=$5
|
KES Financial Incentive 4
n=43 Participants
KES financial incentive 4=$10
|
All Females
n=237 Participants
Total females enrolled
|
|---|---|---|---|---|---|---|
|
Number of Caregivers With Age Less Than Median Presenting Children for HIV Testing
|
15 Participants
|
19 Participants
|
22 Participants
|
26 Participants
|
26 Participants
|
108 Participants
|
SECONDARY outcome
Timeframe: 2 monthsNumber of caregivers presenting children for HIV testing stratified by caregiver age (caregiver \>38 years)
Outcome measures
| Measure |
No Incentive
n=43 Participants
KES financial incentive=$0
|
KES Financial Incentive 1
n=39 Participants
KES financial incentive 1=$1.25
|
KES Financial Incentive 2
n=43 Participants
KES financial incentive 2=$2.50
|
KES Financial Incentive 3
n=45 Participants
KES financial incentive 3=$5
|
KES Financial Incentive 4
n=45 Participants
KES financial incentive 4=$10
|
All Females
n=215 Participants
Total females enrolled
|
|---|---|---|---|---|---|---|
|
Number of Caregivers With Age More Than Median Presenting Children for HIV Testing
|
16 Participants
|
12 Participants
|
22 Participants
|
25 Participants
|
28 Participants
|
103 Participants
|
Adverse Events
No Incentive
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
KES Financial Incentive 1
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
KES Financial Incentive 2
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
KES Financial Incentive 3
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
KES Financial Incentive 4
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place